MedTrace Logo

DHL Survey on Generative AI for MyChart Messaging

NCT06108037 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1454

Last updated 2023-12-13

No results posted yet for this study

Summary

The purpose of this study is to understand how patients feel about the use of computer programs to create responses when they send electronic messages to their doctors.

Conditions

  • Communication

Interventions

BEHAVIORAL

Generative AI for electronic communication and disclosure

We will use a large language model such as GPT 3.5 to automatically generate responses to fictional messages to a physician. We will disclose whether the message was generated using this technology or not. There are 3 clinical scenarios and 6 pairs of human/AI response and human disclosure/AI disclosure/not disclosed that will test patient attitudes toward this technology.

Sponsors & Collaborators

Principal Investigators

  • Anand Chowdhury, MD, MMCi · Duke University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-31
Primary Completion
2023-12-11
Completion
2023-12-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06108037 on ClinicalTrials.gov